The Impact of Nasal Staphylococcus aureus Carriage on Surgical-Site Infections after Immediate Breast Reconstruction: Risk Factors and Biofilm Formation Potential

13 September 2023 : Clinical Research

Maria Szymankiewicz

^1ABCDEF*, Sylwia Jarzynka

^2CDF, Anna Koryszewska-Bagińska

^2DF, Tomasz Nowikiewicz

^34BDF

DOI: 10.12659/MSM.940898

Med Sci Monit 2023; 29:e940898

Table 2 The influence of analyzed factors on the risk of infection: univariate analysis.

Factors	Level	Odds ratio (95% confidence interval)	P (logistic regression)
	(Continuous variable)	0.98 (0.91, 1.07)	0.7162
	(Continuous variable)	1.01 (0.87, 1.18)	0.8887
	Invasive	1 (ref.)
	Pre-invasive	Estimation not possible	0.9977
	I	1 (ref.)
	II	0.58 (0.06, 0)	0.6319
	III	0.58 (0.03, 10.21)	0.7089
	Prosthesis	1 (ref.)
	Expander	7.64 (0.89, 65.31)	0.0634
	Negative	1 (ref.)
	Positive	0.4 (0.05, 3.41)	0.3993
	No	1 (ref.)
	Yes	Estimation not possible	0.9974
	No	1 (ref.)
	Yes	4.01 (0.75, 21.5)	0.1049
	0	1 (ref.)
	1	4 (0.43, 37.01)	0.222
	2	4.95 (0.43, 57.59)	0.2012
^*	No	1 (ref.)
^*	Yes	4.27 (0.5, 36.57)	0.1848
	No	1 (ref.)
	Yes	1.98 (0.36, 10.9)	0.4321
BMI – body mass index; ASA – American Society of Anesthesiologists; PCR – polymerase chain reaction; MSSA – methicillin-susceptible ; MRSA – methicillin-resistant ; CHTH – chemotherapy (adjuvant or neoadjuvant). ^* Risk factors: diabetes mellitus, mitral valve regurgitation, myocardial infarction, bronchial asthma, hypertension, thrombocytopenia, smoking, COVID disease, coronavirus disease, CHTH treatment, chemotherapy (adjuvant or neoadjuvant). .